Chemical Class Description: Galanin inhibitors, as a chemical class, encompass a range of compounds that indirectly modulate the activity of galanin by targeting various components of its signaling pathways. These inhibitors do not directly interact with galanin or its receptors but influence the intracellular processes that are initiated upon galanin receptor activation. For instance, inhibitors like Wortmannin and LY294002 target the PI3K pathway, which is crucial for the transduction of signals from the galanin receptor to intracellular effectors. Similarly, U73122 and Chelerythrine interfere with the enzymatic activity of phospholipase C and protein kinase C, respectively, both of which are pivotal in the galanin-mediated signaling cascade.
Further, compounds like Rapamycin, Genistein, and SB203580 disrupt the mTOR, tyrosine kinase, and p38 MAPK pathways, respectively, all of which can be involved in the downstream effects of galanin receptor activation. PD98059 and BAPTA-AM target the MEK pathway and intracellular calcium levels, each playing a significant role in the cellular response to galanin. Forskolin, Y-27632, and PP2 represent another dimension of this class, modulating adenylate cyclase activity, Rho-associated protein kinase, and Src family kinases, respectively.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
Inhibits PI3K, a kinase involved in galanin receptor signaling. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
Another PI3K inhibitor, reducing downstream signaling of galanin receptors. | ||||||
Chelerythrine chloride | 3895-92-9 | sc-3547 sc-3547A | 5 mg 25 mg | $88.00 $311.00 | 17 | |
Inhibits protein kinase C, which is activated by galanin receptor pathways. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
Inhibits mTOR, which may be involved in downstream effects of galanin signaling. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $26.00 $92.00 $120.00 $310.00 $500.00 $908.00 $1821.00 | 46 | |
Tyrosine kinase inhibitor, potentially affecting galanin receptor signaling. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
Inhibits p38 MAPK, a kinase potentially involved in galanin signaling pathways. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
Inhibits MEK, which is part of the MAPK pathway linked to galanin receptor activity. | ||||||
BAPTA/AM | 126150-97-8 | sc-202488 sc-202488A | 25 mg 100 mg | $138.00 $449.00 | 61 | |
Chelates calcium, affecting intracellular signaling of galanin receptors. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Activates adenylate cyclase, potentially disrupting galanin receptor-mediated signaling. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $182.00 $693.00 | 88 | |
ROCK inhibitor, possibly influencing cytoskeletal rearrangements in galanin signaling. |